The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Open accessAbstract
BACKGROUND: Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as first-line treatment. We compared the two. METHODS: In this observer-masked, randomised controlled trial treatment-naive patients with open angle glaucoma or ocular hypertension and no ocular comorbidities were recruited between 2012 and 2014 at six UK hospitals. They were randomly allocated (web-based randomisation) to initial selective laser trabeculoplasty or to eye drops. An objective target intraocular pressure was set according to glaucoma severity. The primary outcome was health-related quality of life (HRQoL) at 3 years (assessed by EQ-5D). Secondary outcomes were cost and cost-effectiveness, disease-specific HRQoL, clinical effectiveness, and safety. Analysis was by intention to treat. This study is registered at controlled-trials.com (ISRCTN32038223). FINDINGS: Of 718 patients enrolled, 356 were randomised to the selective laser trabeculoplasty and 362 to the eye drops group. 652 (91%) returned the primary outcome questionnaire at 36 months. Average EQ-5D score was 0·89 (SD 0·18) in the selective laser trabeculoplasty group versus 0·90 (SD 0·16) in the eye drops group, with no significant difference (difference 0·01, 95% CI -0·01 to 0·03; p=0·23). At 36 months, 74·2% (95% CI 69·3-78·6) of patients in the selective laser trabeculoplasty group required no drops to maintain intraocular pressure at target. Eyes of patients in the selective laser trabeculoplasty group were within target intracoluar pressure at more visits (93·0%) than in the eye drops group (91·3%), with glaucoma surgery to lower intraocular pressure required in none versus 11 patients. Over 36 months, from an ophthalmology cost perspective, there was a 97% probability of selective laser trabeculoplasty as first treatment being more cost-effective than eye drops first at a willingness to pay of £20 000 per quality-adjusted life-year gained. INTERPRETATION: Selective laser trabeculoplasty should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice. FUNDING: National Institute for Health Research, Health and Technology Assessment Programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,705
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,320
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath, D. F., Crabb, D. P., Bunce, C., Lascaratos, G., Amalfitano, F., Anand, N., Azuara-Blanco, A., Bourne, R. R., Broadway, D. C., Cunliffe, I. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62111-5 · Cited by 660
Self-citationCategorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage Disease
Mills, R. P., Budenz, D. L., Lee, P. P., Noecker, R. J., Walt, J. G., Siegartel, L. R., Evans, S. J., & Doyle, J. J. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.07.044 · Cited by 484
Primary Open-Angle Glaucoma Preferred Practice Pattern®
Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., Li, T., & Mansberger, S. L. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.10.022 · Cited by 474
Adherence and Persistence with Glaucoma Therapy
Schwartz, G. F., & Quigley, H. A. (2008) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.08.002 · Cited by 337
Categorizing the Stage of Glaucoma From Prediagnosis to End-Stage Disease
Brusini, P. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.03.002 · Cited by 336
Risk of Falls and Motor Vehicle Collisions in Glaucoma
Haymes, S. A., LeBlanc, R. P., Nicolela, M. T., Chiasson, L. A., & Chauhan, B. C. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0886 · Cited by 311
Leading causes of certification for blindness and partial sight in England & Wales
Bunce, C., & Wormald, R. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-58 · Cited by 245
Self-citation
Cited by
Glaucoma in Adults—Screening, Diagnosis, and Management: A Review
Stein, J. D., Khawaja, A. P., & Weizer, J. S. (2021) · JAMA · doi:10.1001/jama.2020.21899 · Cited by 728
Jayaram, H., Kolko, M., Friedman, D. S., & Gazzard, G. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01289-8 · Cited by 592
Self-citationPrimary Open-Angle Glaucoma Preferred Practice Pattern®
Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., Li, T., & Mansberger, S. L. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.10.022 · Cited by 474
Kang, J. M., & Tanna, A. P. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.01.004 · Cited by 342
Vickerstaff, V., Ambler, G., & Omar, R. Z. (2021) · Biometrical Journal · doi:10.1002/bimj.201900040 · Cited by 26
Self-citation
Metadata
- Authors
- Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., Garg, A., Vickerstaff, V., Hunter, R., Ambler, G., Bunce, C., Wormald, R., Nathwani, N., Barton, K., Rubin, G., Buszewicz, M., Ambler, G., Barton, K., Bourne, R., Broadway, D., Bunce, C., Buszewicz, M., Davis, A., Garg, A., Garway-Heath, D., Gazzard, G., Hunter, R., Jayaram, H., Jiang, Y., Konstantakopoulou, E., Lim, S., Liput, J., Manners, T., Morris, S., Nathwani, N., Rubin, G., Strouthidis, N., Vickerstaff, V., Wilson, S., Wormald, R., & Zhu, H.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 393
- Issue
- 10180
- Pages
- 1505-1516
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2921734131
- Cited by
- 576
- References
- 21
- FWCI
- 58.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(18)32213-x
- The paper
- Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., Garg, A., Vickerstaff, V., Hunter, R., Ambler, G., Bunce, C., Wormald, R., Nathwani, N., Barton, K., Rubin, G., Buszewicz, M., Ambler, G., Barton, K., Bourne, R., Broadway, D., Bunce, C., Buszewicz, M., . . . Zhu, H. (2019). Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(18)32213-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.